EPO Patents = 1

Forward Citations = 156

Loading Chart...

2 inventors (with patents filed for the assignee):

Michael P Wallace (5 out of 147 patents)

Justin Panian (1 out of 11 patents)

Justin Panian (0 patent)

6 patents: Sort by Forward Citations

1. 11364043 - Methods and devices for endovascular therapy (2022-06-21),

2. 11116528 - Methods and devices for endovascular therapy (2021-09-14),

3. 11039845 - Methods and devices for endovascular therapy (2021-06-22),

4. 10980555 - Methods and devices for clots and tissue removal (2021-04-20),

5. 10959750 - Methods and devices for removing obstructing material from the human body (2021-03-30),

6. 9375223 - Methods and devices for endovascular therapy (2016-06-28),

Cardioprolific Inc. is a leading medical device company specializing in developing innovative solutions for cardiovascular diseases. Our mission is to improve patient outcomes and quality of life through cutting-edge technologies. We pride ourselves on our commitment to research and development, ensuring that our products are at the forefront of the industry. With a focus on excellence and innovation, Cardioprolific Inc. is dedicated to advancing the field of cardiology and transforming the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

6 Patents

#86 in Reno, NV

#385 in Nevada

#43,910 in US

Reno, NV, United States of America

Cardioprolific Inc.

Forward Citations = 156

2 inventors:

Michael P Wallace (5 out of 147 patents)

Justin Panian (1 out of 11 patents)

Justin Panian (0 patent)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com